Description

Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1].–Applications-COVID-19-anti-virus-Formula-N/A-Citation–References-[1]Wang YH, et, al. Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury. Front Pharmacol. 2018 Jun 15;9:636.-CASNumber-556743-18-1-MolecularWeight-N/A-Compound Purity–SMILES-[Lumbokinase capsules]-Research_Area-Inflammation/Immunology-Solubility-10 mM in DMSO-Target-Sirtuin-Isoform-SIRT1-Pathway-Cell Cycle/DNA Damage;Epigenetics-MCE Product type-Enzyme